Uytengsu-Hamilton 22q11 Neuropsychiatry Research Awards Program

FY 2021 Awards

Mark Kay, MD PhD
Professor, Pediatrics (Human Gene Therapy) and Genetics, Stanford School of Medicine 
Study Title: Developing Novel Adeno-associated Virus Vectors for Gene Therapy of 22q11.2 Deletion Syndrome

Michael Lin, MD PhD
Associate Professor, Neurobiology and Bioengineering, Stanford University   
Study Title: Visualizing and reversing electrical abnormalities in a mouse model of 22q11.2 deletion syndrome

Anca Pasca, MD
Assistant Professor, Pediatrics (Neonatology), Stanford School of Medicine
Study Title: Identification of Metabolic Disturbances in the Developing Brain of Individuals with 22q11.2 Deletion Syndrome

Lei Stanley Qi, PhD
Associate Professor, Bioengineering and Chemical and Systems Biology, Stanford University
Study Title: Systematic Identification and Correction of Genes Defining the Neuropsychiatric Phenotype in 22q11 Deletion Syndrome using the CRISPR Toolbox

Therese van Amelsvoort, MD PhD
Professor, Psychiatry and Neuropsychology, Maastricht University
Study Title: The glutamate/GABA balance as novel therapeutic target for psychotic and cognitive symptoms in 22q11.2 deletion syndrome

Stanislav Zakharenko, MD PhD
Professor, Developmental Neurobiology, St Jude Children’s Research Hospital
Study Title: Focal cerebellar abnormality in patients and mouse models of 22q11 deletion syndrome

FY 2020 Awards

Vinod Menon, PhD
Professor, Psychiatry & Behavioral Sciences
Study Title: Leveraging Big Data and Using Deep Learning Neural Networks to Predict Progression of Psychosis in 22q11 DS

Thomas Sudhof, MD
Professor, Molecular and Cellular Physiology
Study Title: Multi-level Analysis of Mouse and Human Neurons with the 22q11.2 Deletion

Alexander Urban, PhD 
Assistant Professor, Psychiatry & Behavioral Sciences and Genetics
Study Title: A Genome Analysis Method to Detect and Resolve the Exact Boundaries of the 22q11 Deletion